New combo therapy may offer relief for chronic watery eyes

NCT ID NCT07372014

Ongoing Symptom relief Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares using an anti-inflammatory eye drop (nepafenac) plus a lubricant versus a lubricant alone to treat watery eyes (epiphora) caused by narrowing of the tear duct opening. Researchers will measure changes in tear duct size and symptom severity in 68 Mexican adults. The goal is to see if adding the anti-inflammatory drop provides better relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPIPHORA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Constriction, Pathologic excessive tearing lacrimal apparatus disorder stenosis of lacrimal punctum

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPIPHORA PUNCTAL STENOSIS

Contacts and locations

Locations

Instituto de Oftalmología F.A.P. Conde de Valenciana, I.A.P.

Mexico City, Mexico City, 06800, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.